Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events
-
By
-
Olivia Anderson
-
October 21, 2026
-
3 min
Clinical Scorecard: Uncomplicated UTIs: Courses of at least 8 days associated with higher adverse-event rates
At a Glance
Category | Detail |
|---|---|
Condition | Symptomatic uncomplicated urinary tract infections |
Key Mechanisms | The study evaluated associations between antibiotic treatment duration and treatment-related adverse-event rates; it did not establish causation. |
Target Population | 57,448 female patients aged 12 years or older who received an antibiotic prescription within 5 days of diagnosis and had at least 12 months of prior electronic health record activity |
Care Setting | U.S. electronic health records from Optum’s de-identified Market Clarity database covering May 2023 through March 2025 |
Key Highlights
The retrospective study compared antibiotic courses lasting at least 8 days with courses lasting 5 to 7 days.
Extended treatment was associated with a 20% higher overall rate of treatment-related adverse events (rate ratio, 1.20; 95% CI, 1.09–1.32; P < 0.001).
Higher rates were also reported for gastrointestinal, genitourinary, endocrine and hypersensitivity events.
Patients receiving extended treatment were older on average and had more coexisting medical conditions.
Nitrofurantoin was the most commonly prescribed antibiotic in both groups.
Findings were presented at IDWeek 2026.
Guideline-Based Recommendations
The source article reports an observational study and the authors’ stewardship interpretation rather than a clinical guideline.
Diagnosis
Eligible patients had symptomatic uncomplicated urinary tract infections and received an antibiotic prescription within 5 days of diagnosis.
The source article does not provide detailed diagnostic criteria or testing recommendations.
Management
The authors emphasized aligning antibiotic treatment duration with antimicrobial stewardship guidelines.
The comparison involved courses lasting at least 8 days versus 5 to 7 days; it did not establish the optimal duration for each antibiotic.
Other commonly prescribed agents included beta-lactams, trimethoprim-sulfamethoxazole and fluoroquinolones.
The source article does not provide agent-specific treatment recommendations or doses.
Monitoring & Follow-up
Treatment duration was categorized during a 7-day period beginning with the first antibiotic prescription.
Treatment-related adverse events were assessed for up to 90 days after that period.
This was the study’s observation window, not a recommended patient follow-up schedule.
Risks
Extended treatment was associated with higher rates of gastrointestinal events (rate ratio, 1.42; 95% CI, 1.24–1.63), genitourinary events (1.52; 95% CI, 1.25–1.84), endocrine events (1.40; 95% CI, 1.02–1.91) and hypersensitivity events (2.38; 95% CI, 1.28–4.40).
The retrospective design does not establish that longer treatment caused these events.
Absolute adverse-event rates and detailed event definitions were not provided in the source article.
Patient & Prescribing Data
Of 57,448 eligible patients, 17,867 (31.1%) received treatment lasting at least 8 days and 39,581 (68.9%) received treatment lasting 5 to 7 days.
Mean age was 55.1 years in the extended-treatment group versus 52.3 years in the shorter-treatment group. Researchers used propensity score weighting to account for differences in patient characteristics.
Nitrofurantoin accounted for 39% of prescriptions in the extended-treatment group and 46.1% in the 5-to-7-day group.
GSK funded the study. Several authors were GSK employees, some reported stock ownership, and Analysis Group received GSK funding to conduct the study. One co-author also reported research support from Pfizer.
Clinical Best Practices
Align antibiotic duration with applicable stewardship guidance, as emphasized by the authors.
Distinguish the study’s duration categories from agent-specific prescribing recommendations.
Interpret the 20% increase as a relative difference in adverse-event rates, not a 20-percentage-point increase or an absolute event rate.
Recognize that propensity score weighting addressed patient-characteristic differences but does not turn the observational findings into proof of causation.
Related Resources & Content
Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events — Olivia Anderson — IDSA Reporter — October 21, 2026.
IDWeek 2026 — Conference at which the findings were presented, according to the source article.
Based on findings from:
Uncomplicated UTIs: Antibiotics lasting over 7 days tied to adverse events
Olivia Anderson. Idsa Reporter, 2026.
https://idsareporter.com/issues/2026/october-2026/uncomplicated-utis-antibiotics-lasting-over-7-days-tied-to-adverse-events/
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.